用于治疗肝细胞癌的特梅利马布
Miguel Sogbe1, Paloma Sangro2,3, Manuel de la Torre-Aláez2,3
1Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra, Pamplona, Spain.
Expert opinion on biological therapy
|August 20, 2025
概括
这是一种抗CTLA-4抗体,它改变了肝细胞癌的治疗方法. 它在组合疗法中表现有前途,特别是在先进的HCC中,正在进行的研究正在探索早期阶段.
科学领域:
- 肝细胞癌 (HCC) 研究
- 在瘤学中的免疫疗法
- 临床药理学
背景情况:
- 肝细胞癌 (HCC) 是全球主要的癌症死亡原因.
- 传统的氨酸激酶抑制剂对HCC的有效性有限.
- 免疫疗法已经彻底改变了HCC的治疗方法.
研究的目的:
- 审查特梅利穆巴的药理学,疗效和安全性.
- 探索特梅利穆马布在HCC不同阶段的作用.
- 讨论正在进行的临床试验和未来的特梅利木马布治疗方向.
主要方法:
- 对特梅利穆马布的药理分析.
- 综合临床试验证据 (单疗法和组合疗法).
- 审查正在进行的研究和未来的前景.
主要成果:
- 特雷梅利穆巴治疗HCC,特别是与杜尔瓦卢马布联合治疗.
- 这种组合可诱导持久的免疫反应,具有良好的安全性.
- 对早期和中期HCC进行研究.
结论:
- 特雷米利穆巴是高级HCC治疗的关键药物.
- 对HCC的新辅助和转化疗法的潜力.
- 需要预测生物标志物来优化特梅利木马布在HCC中的使用.
更多相关视频
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231